US Map / Oregon
State OR

Clinical Trials in Oregon

Oregon is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Oregon and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 195 actively recruiting studies with Oregon sites out of 195 registered in total. The busiest research areas in Oregon are Breast Cancer, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Oregon Health and Science University, National Cancer Institute (NCI), VA Office of Research and Development. By stage, Oregon trials break down as Phase 1 (25), Phase 2 (49), Phase 3 (55), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
195
Recruiting Now
195
← Back to US Map
Top Conditions in Oregon
Breast Cancer (7)Endometrial Cancer (6)Advanced Solid Tumor (5)Ovarian Cancer (4)Colorectal Cancer (4)Multiple Myeloma (4)Metastatic Solid Tumor (3)Cancer (3)Lung Cancer (3)Prostate Cancer (3)Thyroid Cancer (3)NSCLC (Non-small Cell Lung Cancer) (3)

Frequently Asked Questions — Clinical Trials in Oregon

How many clinical trials are currently recruiting in Oregon?
ClinicalMetric currently tracks 195 actively recruiting clinical trials with at least one location in Oregon. The total number of registered studies—including active but not currently enrolling trials—is 195. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Oregon?
Oregon hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Oregon serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Oregon?
To join a clinical trial in Oregon, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Oregon maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Oregon

NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03550391 Phase 3
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radioth...
Condition
Brain Metastases
Enrollment
206 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT07187115 N/A
Recruiting
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping ...
Condition
Atrial Fibrillation (AF)
Enrollment
699 pts
Location
United States, Belgium, France
Sponsor
Boston Scientific Corporation
View Trial →
NCT06952504 Phase 3
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrol...
Condition
Endometrial Cancer
Enrollment
1,123 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Condition
Acute Myeloid Leukemia
Enrollment
130 pts
Location
United States, Australia, Austria
Sponsor
PedAL BCU, LLC
View Trial →
NCT04251052 N/A
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations t...
Condition
Ovarian Carcinoma
Enrollment
1,956 pts
Location
United States, Canada, South Korea
Sponsor
NRG Oncology
View Trial →
NCT07482176 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
View Trial →
NCT06257693 Phase 1
Recruiting
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Condition
Prostate Adenocarcinoma
Enrollment
56 pts
Location
United States
Sponsor
Alessa Therapeutics Inc.
View Trial →
NCT07286149 Phase 1, Phase 2
Recruiting
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer...
Condition
Lung Neoplasm Malignant
Enrollment
190 pts
Location
United States, Brazil, Chile
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05237258 N/A
Recruiting
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute...
Condition
Relapsed Adult AML
Enrollment
2,300 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT05820672 N/A
Recruiting
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With...
Condition
Growth Hormone Deficiency
Enrollment
900 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
View Trial →
NCT05235165 Phase 3
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients ...
Condition
Metastatic Malignant Neoplasm in the Lung
Enrollment
62 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06319911 N/A
Recruiting
AETOS Shoulder System
Condition
Shoulder Osteoarthritis
Enrollment
220 pts
Location
United States
Sponsor
Smith & Nephew, Inc.
View Trial →
NCT07094971 N/A
Recruiting
Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Musc...
Condition
Muscle Tone
Enrollment
44 pts
Location
United States
Sponsor
Sofwave Medical LTD
View Trial →
NCT02981628 Phase 2
Recruiting
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma...
Condition
Recurrent B Acute Lymphoblastic Leukemia
Enrollment
80 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT06460012 N/A
Recruiting
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
Condition
Caregiver Burden
Enrollment
238 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT07406633 Phase 2
Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIS...
Condition
GIST - Gastrointestinal Stromal Tumor
Enrollment
46 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT06806033 Phase 2
Recruiting
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile fo...
Condition
B-Cell Non-Hodgkins Lymphoma
Enrollment
100 pts
Location
United States, Australia, Canada
Sponsor
Hoffmann-La Roche
View Trial →
NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (...
Condition
Breast Cancer
Enrollment
750 pts
Location
United States, Belgium, France
Sponsor
Greenwich LifeSciences, Inc.
View Trial →
NCT05685433 N/A
Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Eval...
Condition
Overactive Bladder
Enrollment
200 pts
Location
United States
Sponsor
Valencia Technologies Corporat
View Trial →
NCT06932263 Phase 2
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults ...
Condition
Asthma
Enrollment
540 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT03874052 Phase 1
Recruiting
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treat...
Condition
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Enrollment
51 pts
Location
United States
Sponsor
Jennifer Saultz
View Trial →
NCT07296484 Phase 2
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Condition
Type 2 Diabetes
Enrollment
1,500 pts
Location
United States
Sponsor
Sparrow Pharmaceuticals
View Trial →
Page 4 of 8 — 195 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology